- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06539312
Project ASTHMA - Aligning With Schools To Help Manage Asthma and Improve Outcomes
January 20, 2026 updated by: Lucy Holmes, MD, State University of New York at Buffalo
Project ASTHMA - Aligning With Schools To Help Manage Asthma and Decrease Health Inequities
Children with asthma from communities that experience health inequities frequently do not receive guideline-based asthma care, and as a result, account for a disproportionate percentage of asthma exacerbations, emergency department visits, and hospitalizations.
Project ASTHMA (Aligning with Schools To Help Manage Asthma) tests the effectiveness of school-based health centers as a delivery model to improve health outcomes by providing children with guideline-based asthma assessments and preventive medication management, directly observed therapy of their preventive medication to support adherence, and self-management support.
If successful, this multicomponent intervention will represent a cost effective and sustainable model to reduce asthma morbidity in historically marginalized communities, and has the potential to impact communities throughout the United States where over 2,500 school-based health centers operate.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
400
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Lucy CY Holmes, MD, MPH
- Phone Number: 716-323-0034
- Email: LHolmes@upa.chob.edu
Study Contact Backup
- Name: Deanna Hamilton, MSEd
- Phone Number: 716-323-0060
- Email: DeHamilton@upa.chob.edu
Study Locations
-
-
New York
-
Buffalo, New York, United States, 14203
- Recruiting
- University at Buffalo, Department of Pediatrics
-
Contact:
- Lucy Holmes, MD, MPH
- Phone Number: 716-323-0034
- Email: LHolmes@upa.chob.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- uncontrolled asthma
Exclusion Criteria:
- other chronic lung disease such as cystic fibrosis
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: SBHC group
|
APPs will be trained to follow NIH guidelines for assessment and management of asthma, and to apply their knowledge to the care of the students.
Students will also receive DOT of the morning dose of their controller medication.
Other Names:
|
|
No Intervention: PCP group
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Asthma exacerbations
Time Frame: from 1 month after enrollment to the end of the school year for 1 school year; to be assessed after the end of the school year.
|
Number of asthma exacerbations requiring systemic steroids based on medical records
|
from 1 month after enrollment to the end of the school year for 1 school year; to be assessed after the end of the school year.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Spirometry - FEV1
Time Frame: to be assessed at baseline and 1-, 3-, 5- and 7-months after enrollment for 1 school year
|
Forced Expiratory Volume in 1 second
|
to be assessed at baseline and 1-, 3-, 5- and 7-months after enrollment for 1 school year
|
|
Spirometry - FEV1/FVC ratio
Time Frame: to be assessed at baseline and 1-, 3-, 5- and 7-months after enrollment for 1 school year
|
FEV1/Forced Vital Capacity ratio
|
to be assessed at baseline and 1-, 3-, 5- and 7-months after enrollment for 1 school year
|
|
ED visits
Time Frame: from 1 month after enrollment to the end of the school year for 1 school year; to be assessed after the end of the school year.
|
Number of ED visits for asthma symptoms based on medical records
|
from 1 month after enrollment to the end of the school year for 1 school year; to be assessed after the end of the school year.
|
|
Urgent care visits
Time Frame: from 1 month after enrollment to the end of the school year for 1 school year; to be assessed after the end of the school year.
|
Number of urgent care visits for asthma symptoms based on medical records
|
from 1 month after enrollment to the end of the school year for 1 school year; to be assessed after the end of the school year.
|
|
Hospitalizations
Time Frame: from 1 month after enrollment to the end of the school year; to be assessed after the end of the school year.
|
Number of hospitalizations based on medical records
|
from 1 month after enrollment to the end of the school year; to be assessed after the end of the school year.
|
|
school absenteeism
Time Frame: from 1 month after enrollment to the end of the school year for 1 school year; to be assessed after the end of the school year.
|
Number of missed school days based on school records
|
from 1 month after enrollment to the end of the school year for 1 school year; to be assessed after the end of the school year.
|
|
Daytime asthma symptoms
Time Frame: to be assessed at baseline and 1-, 3-, 5- and 7-months after enrollment for 1 school year
|
Frequency of daytime asthma symptoms based on questionnaire minimum value: 0 days maximum value: 28 days Higher scores mean a worse outcome.
|
to be assessed at baseline and 1-, 3-, 5- and 7-months after enrollment for 1 school year
|
|
Nighttime asthma symptoms
Time Frame: to be assessed at baseline and 1-, 3-, 5- and 7-months after enrollment for 1 school year
|
Frequency of nighttime asthma symptoms based on questionnaire minimum value: 0 nights maximum value: 28 nights Higher scores mean a worse outcome.
|
to be assessed at baseline and 1-, 3-, 5- and 7-months after enrollment for 1 school year
|
|
Quality of Life - caregiver
Time Frame: to be assessed at baseline and at 7-month follow-up for 1 school year
|
Children's Health Survey for Asthma, American Academy of Pediatrics Higher scores mean a better outcome.
|
to be assessed at baseline and at 7-month follow-up for 1 school year
|
|
Activity Limitation
Time Frame: to be assessed at baseline and 1-, 3-, 5- and 7-months after enrollment for 1 school year
|
Degree of activity limitation based on questionnaire Higher scores mean a worse outcome.
|
to be assessed at baseline and 1-, 3-, 5- and 7-months after enrollment for 1 school year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 27, 2024
Primary Completion (Estimated)
April 30, 2028
Study Completion (Estimated)
April 30, 2028
Study Registration Dates
First Submitted
July 31, 2024
First Submitted That Met QC Criteria
August 2, 2024
First Posted (Actual)
August 6, 2024
Study Record Updates
Last Update Posted (Actual)
January 22, 2026
Last Update Submitted That Met QC Criteria
January 20, 2026
Last Verified
April 1, 2025
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Immune System Diseases
- Respiratory Tract Diseases
- Lung Diseases
- Bronchial Diseases
- Lung Diseases, Obstructive
- Respiratory Hypersensitivity
- Hypersensitivity, Immediate
- Hypersensitivity
- Behavior
- Treatment Adherence and Compliance
- Health Behavior
- Patient Compliance
- Patient Acceptance of Health Care
- Medication Adherence
- Asthma
- Directly Observed Therapy
Other Study ID Numbers
- STUDY00007712
- R01MD018384 (U.S. NIH Grant/Contract)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Asthma in Children
-
Montefiore Medical CenterNational Heart, Lung, and Blood Institute (NHLBI)RecruitingAsthma in ChildrenUnited States
-
Meyer Children's Hospital IRCCSRecruitingAsthma in Children | Asthma Acute | Asthma Crisis | Asthma ChildhoodItaly
-
University of MiamiEnrolling by invitationAsthma in Children | Artificial IntelligenceUnited States
-
Istituto di Farmacologia Traslazionale - sede di...Not yet recruitingAsthma in Children | Children, Only | Serious Game
-
Children's Hospital of PhiladelphiaNational Heart, Lung, and Blood Institute (NHLBI)Recruiting
-
University of FloridaNational Heart, Lung, and Blood Institute (NHLBI)CompletedAsthma in ChildrenUnited States
-
ResMedCompletedAsthma in ChildrenUnited States
-
University of WashingtonNational Institute of Environmental Health Sciences (NIEHS); National Institute... and other collaboratorsCompleted
-
Children's Hospital Medical Center, CincinnatiNational Heart, Lung, and Blood Institute (NHLBI)Not yet recruiting
Clinical Trials on APP assessment and management of asthma
-
State University of New York at BuffaloNational Center for Advancing Translational Sciences (NCATS)Completed
-
Restech SrlRecruitingAsthmaItaly, Australia, France
-
Icahn School of Medicine at Mount SinaiUniversity of Colorado, Denver; National Heart, Lung, and Blood Institute (NHLBI)Completed
-
Denver Health and Hospital AuthorityUniversity of Colorado, DenverCompleted
-
Children's Hospital of Eastern OntarioCHAMO Innovation FundCompleted
-
Chongqing Renji Hospital, University of Chinese...Not yet recruiting
-
Griffith UniversityNot yet recruitingChronic Kidney DiseaseVietnam
-
University of MichiganCompleted
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)Completed
-
Fred Hutchinson Cancer Research Center/University...National Cancer Institute (NCI)CompletedDepression | Fatigue | Primary Myelofibrosis | Stage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Chronic Myelomonocytic Leukemia | Recurrent Adult Acute Myeloid Leukemia | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone... and other conditionsUnited States